Skip to main content
Log in

Mifepristone provides clear QOL benefit in uterine leiomyoma

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Fiscella K, Eisinger SH, Meldrum S, Feng C, Fisher SG, Guzick DS.Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial. Obstetrics and Gynecology 108: 1381-1387, No. 6, Dec 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mifepristone provides clear QOL benefit in uterine leiomyoma. Pharmacoecon. Outcomes News 519, 9 (2007). https://doi.org/10.2165/00151234-200705190-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705190-00027

Keywords

Navigation